Equities

Fisher & Paykel Healthcare Corporation Ltd

Fisher & Paykel Healthcare Corporation Ltd

Actions
Health CareHealth Care Equipment & Services
  • Price (NZD)16.76
  • Today's Change-0.24 / -1.41%
  • Shares traded181.38k
  • 1 Year change9.40%
  • Beta1.6275
Data delayed at least 20 minutes, as of Sep 18 2019 05:59 BST.
More ▼

Forecasts data is unavailable for this security.

Consensus recommendation

As of Sep 13, 2019, the consensus forecast amongst 7 polled investment analysts covering Fisher & Paykel Healthcare Corp Ltd advises that the company will underperform the market. This has been the consensus forecast since the sentiment of investment analysts deteriorated on May 28, 2018. The previous consensus forecast advised investors to hold their position in Fisher & Paykel Healthcare Corp Ltd.
  • 1yr ago
  • 3M ago
  • 2M ago
  • 1M ago
  • Latest
Select bar for recommendation details.
RecommendationsLatest
Buy0
Outperform0
Hold2
Underperform3
Sell2

Share price forecast

The 6 analysts offering 12 month price targets for Fisher & Paykel Healthcare Corp Ltd have a median target of 14.08, with a high estimate of 16.61 and a low estimate of 12.25. The median estimate represents a -16.02% decrease from the last price of 16.76.
High-0.9%16.61
Med-16.0%14.08
Low-26.9%12.25

Dividends

In 2019, Fisher & Paykel Healthcare Corporation Ltd reported a dividend of 0.26 NZD, which represents a 20.62% increase over last year. The 8 analysts covering the company expect dividends of 0.28 NZD for the upcoming fiscal year, an increase of 9.63%.
Div growth (TTM)20.62%
More ▼

Earnings history & estimates

On May 26, 2019, Fisher & Paykel Healthcare Corp Ltd reported semi annual 2019 earnings of 0.193 per share.
Average growth rate+38.87%
Fisher & Paykel Healthcare Corp Ltd reported annual 2019 earnings of 0.362 per share on May 26, 2019.
The next earnings announcement from Fisher & Paykel Healthcare Corp Ltd is expected the week of May 26, 2020.
Average growth rate+16.30%
More ▼

Revenue history & estimates

Fisher & Paykel Healthcare Corporation Limited reported semi annual 2019 revenues of 559.10m. This missed the 564.00m estimate of the one analyst following the company. This was 7.03% above the prior year's period results.
Average growth rate+9.35%
Fisher & Paykel Healthcare Corporation Limited had revenues for the full year 2019 of 1.07bn. This was 9.14% above the prior year's results.
Average growth rate+12.44%
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.